articleTop 1% cited
Adipokines and cytokines in non‐alcoholic fatty liver disease
Alimentary Pharmacology & Therapeutics · 2007 · Vol. 27(5) · pp. 412–421
Mohammed Jarrar✉(Inova Health System)Ancha Baranova(Inova Health System)Rochelle Collantes(Inova Health System)Benjamin L. Ranard(Inova Health System)Maria Stepanova(Inova Health System)Chase Bennett(Inova Health System)Yun Fang(Inova Health System)Hazem Elariny(Inova Health System)Zachary Goodman(Armed Forces Institute of Pathology)Vikas Chandhoke(Inova Health System)Zobair M. Younossi(George Mason University)
Abstract
These findings support a complex interaction between adipocytokines and the pathogenesis of NAFLD.
Liver Disease Diagnosis and TreatmentLipid metabolism and disordersDiet, Metabolism, and DiseaseAdipokineAdiponectinMedicineInternal medicineSteatohepatitisResistinFatty liverEndocrinologySteatosisInsulin resistance
MeSH terms
AdultAgedBiopsyBlood GlucoseFastingFatty LiverFemaleHumansImmunoenzyme TechniquesInsulinInsulin ResistanceLiverLiver CirrhosisMaleMiddle Aged
Citations
427
FWCI
15.68
field-weighted impact
References
35
Percentile
99%
vs. same field & year
Citations per year
Cited by
Oxidative Stress in Obesity: A Critical Component in Human Diseases
International Journal of Molecular Sciences · 2014 · 928 citations
Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments
Alimentary Pharmacology & Therapeutics · 2013 · 407 citations
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
World Journal of Gastroenterology · 2017 · 761 citations
References
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
Gastroenterology · 1999 · 3,359 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.